ABN AMRO Bank N.V. cut its stake in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 143,666 shares of the company's stock after selling 13,081 shares during the quarter. ABN AMRO Bank N.V.'s holdings in Procter & Gamble were worth $20,539,000 at the end of the most recent reporting period.
A number of other hedge funds also recently made changes to their positions in PG. Maseco LLP purchased a new position in Procter & Gamble in the 4th quarter worth approximately $28,000. Saranac Partners Ltd purchased a new stake in shares of Procter & Gamble during the 3rd quarter worth approximately $30,000. Corundum Trust Company INC purchased a new stake in shares of Procter & Gamble during the 3rd quarter worth approximately $32,000. Caitlin John LLC purchased a new stake in shares of Procter & Gamble during the 3rd quarter worth approximately $34,000. Finally, Anfield Capital Management LLC raised its holdings in shares of Procter & Gamble by 121.5% during the 4th quarter. Anfield Capital Management LLC now owns 237 shares of the company's stock worth $34,000 after acquiring an additional 130 shares in the last quarter. 65.77% of the stock is currently owned by institutional investors.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $146.44 on Monday. The stock's fifty day moving average is $148.41 and its two-hundred day moving average is $148.55. The company has a market capitalization of $341.00 billion, a PE ratio of 21.41, a price-to-earnings-growth ratio of 6.28 and a beta of 0.41. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.44. Procter & Gamble Company has a 52 week low of $137.62 and a 52 week high of $170.99.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Friday, April 24th. The company reported $1.59 EPS for the quarter, beating the consensus estimate of $1.56 by $0.03. The company had revenue of $21.24 billion for the quarter, compared to the consensus estimate of $21.52 billion. Procter & Gamble had a return on equity of 32.00% and a net margin of 19.16%.Procter & Gamble's quarterly revenue was up 7.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $1.54 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Increases Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 24th will be given a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a dividend yield of 3.0%. The ex-dividend date of this dividend is Friday, April 24th. This is a positive change from Procter & Gamble's previous quarterly dividend of $1.06. Procter & Gamble's dividend payout ratio is currently 63.60%.
Analyst Ratings Changes
Several analysts have recently issued reports on the company. Raymond James Financial decreased their price objective on Procter & Gamble from $175.00 to $170.00 and set an "outperform" rating on the stock in a report on Tuesday, April 14th. Evercore set a $162.00 price objective on Procter & Gamble in a report on Monday, April 27th. Dbs Bank raised Procter & Gamble from a "hold" rating to a "buy" rating in a report on Friday, January 23rd. Deutsche Bank Aktiengesellschaft reaffirmed a "buy" rating and set a $163.00 price objective on shares of Procter & Gamble in a report on Monday, April 27th. Finally, Barclays decreased their price objective on Procter & Gamble from $155.00 to $146.00 and set an "equal weight" rating on the stock in a report on Tuesday, April 14th. Eleven research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble has an average rating of "Moderate Buy" and a consensus price target of $161.06.
Check Out Our Latest Stock Analysis on Procter & Gamble
Insider Buying and Selling at Procter & Gamble
In related news, Chairman Jon R. Moeller sold 162,232 shares of the company's stock in a transaction on Thursday, February 12th. The stock was sold at an average price of $162.45, for a total transaction of $26,354,588.40. Following the completion of the sale, the chairman directly owned 319,385 shares in the company, valued at $51,884,093.25. This represents a 33.68% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this link. Also, CEO Ma. Fatima Francisco sold 5,549 shares of the company's stock in a transaction on Friday, February 27th. The stock was sold at an average price of $165.29, for a total value of $917,194.21. Following the sale, the chief executive officer owned 1,029 shares of the company's stock, valued at $170,083.41. This trade represents a 84.36% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last ninety days, insiders have sold 244,715 shares of company stock worth $39,702,904. Insiders own 0.20% of the company's stock.
Key Procter & Gamble News
Here are the key news stories impacting Procter & Gamble this week:
About Procter & Gamble
(
Free Report)
Procter & Gamble NYSE: PG is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world's largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.
P&G's product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link to see MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.